Biotech News

Catheter Precision Announces Publication of Comparative Study Showing LockeT Outperforms Abbott’s Perclose Internal Vascular Closure Device

Catheter Precision (VTAK)Catheter PrecisionCompany update

Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced the first published comparative study evaluating its LockeT suture retention device against a traditional internal vascular closure device (VCD) following large bore venous access.

Related news

Catheter Precision

Cardiac Electrophysiology and Aviation Company Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE. The company therefore operates through two distinct segments. VIVO Cardiac Mapping System VIVO is a non-invasive three-dimensional mapping system used...

Recent company news

Stock data

Close
1.51 USD
Market cap
2.58M USD
Exchange
NYSE
Sector
MedTech
Location
United States